Loading clinical trials...
Loading clinical trials...
The aim of this project is to develop evidence that can inform hearing health care best practices for adults between the ages of 65-75, and determine what level of involvement by the primary care prac...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Duke University
Collaborators
NCT07218913 · Hearing Loss, Metastatic Malignant Germ Cell Tumor, and more
NCT07288580 · Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
NCT06782308 · Tinnitus, Subjective, Tinnitus, Bilateral, and more
NCT04915183 · Hearing Loss, Head and Neck Cancer
NCT05572073 · Sensorineural Hearing Loss, Bilateral
University of Michigan
Ann Arbor, Michigan
Northwell Health
New Hyde Park, New York
New York Eye and Ear of Mount Sinai
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions